ActivMed Clinical Trials

Phase I and II clinical trial budgets double over past five years due to staffing, patient enrollment

Monday, June 8, 2015

Early phase clinical trial budgets climbed dramatically during the recent five year period, rising 157% from 2008 to 2013, largely due to increased clinical research associate (CRA) costs and higher per patient costs, according to a just-released study by life sciences intelligence firm Cutting Edge Information. Phase II clinical trial costs also doubled during the same time period.

[Read More]